Red blood cell background graphic

Do you have essential thrombocythemia (ET)?

You may be eligible to join EXCEED ET, a Phase 2b clinical research study in the US and Canada that evaluates the potential of a new, investigational ET therapy to control the number of platelets and white blood cells in the blood.


For more information, contact our Medical Information team at

  • PharmaEssentia USA Corporation
  • 35 Corporate Drive, Suite 325,
  • Burlington, MA 01803, USA